AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 59 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,693 | -29.8% | 66,821 | -28.3% | 0.00% | – |
| Q2 2023 | $221,804 | +452.5% | 93,195 | +327.2% | 0.00% | – |
| Q1 2023 | $40,143 | +0.4% | 21,817 | +15.7% | 0.00% | – |
| Q3 2022 | $40,000 | -33.3% | 18,851 | -10.4% | 0.00% | – |
| Q2 2022 | $60,000 | -96.2% | 21,039 | -94.4% | 0.00% | – |
| Q1 2022 | $1,566,000 | +96.7% | 375,514 | +144.8% | 0.00% | – |
| Q4 2021 | $796,000 | +115.7% | 153,421 | +172.1% | 0.00% | – |
| Q3 2021 | $369,000 | -91.5% | 56,391 | -91.3% | 0.00% | -100.0% |
| Q2 2021 | $4,319,000 | +6443.9% | 650,496 | +5559.4% | 0.00% | – |
| Q1 2021 | $66,000 | -48.8% | 11,494 | -20.1% | 0.00% | – |
| Q4 2020 | $129,000 | -59.8% | 14,385 | -47.8% | 0.00% | – |
| Q3 2020 | $321,000 | -42.2% | 27,574 | -20.4% | 0.00% | – |
| Q2 2020 | $555,000 | +141.3% | 34,632 | -9.8% | 0.00% | – |
| Q1 2020 | $230,000 | +63.1% | 38,388 | +258.2% | 0.00% | – |
| Q4 2019 | $141,000 | -52.7% | 10,716 | -55.4% | 0.00% | – |
| Q3 2019 | $298,000 | +8.8% | 24,011 | +175.4% | 0.00% | – |
| Q1 2019 | $274,000 | +24.5% | 8,720 | +30.3% | 0.00% | – |
| Q4 2018 | $220,000 | – | 6,694 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 7,346,829 | $38,130,000 | 36.42% |
| FRAZIER MANAGEMENT LLC | 3,746,857 | $19,446,000 | 1.50% |
| TFG Asset Management GP Ltd | 2,700,000 | $14,013,000 | 0.84% |
| Nantahala Capital Management | 4,077,509 | $21,162,000 | 0.74% |
| Ikarian Capital, LLC | 544,819 | $2,827,000 | 0.42% |
| HARBOR CAPITAL ADVISORS, INC. | 211,319 | $1,097,000 | 0.40% |
| Blackstone Inc. | 17,985,611 | $93,345,000 | 0.23% |
| Resolute Capital Asset Partners LLC | 65,115 | $338,000 | 0.22% |
| MYDA Advisors LLC | 125,000 | $649,000 | 0.17% |
| Eversept Partners, LP | 401,540 | $2,083,993 | 0.13% |